{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:29:57Z","timestamp":1793046597066,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The role of lymph node dissection in gastric cancer (GC) patients undergoing immune checkpoint inhibitor (ICI) therapy remains unclear. While extensive lymph node dissection has been a cornerstone of GC surgery, its impact on the efficacy of ICIs, which rely on immune functionality, warrants investigation. This retrospective study analyzed 218 GC patients treated with ICIs and compared their outcomes based on the number of lymph nodes dissected. Propensity score matching and multivariate Cox regression analyses were conducted to minimize confounding factors and identify independent prognostic variables. Subgroup analyses were performed based on lymph node metastasis status to explore potential interactions. Patients with fewer lymph node dissections demonstrated significantly longer progression-free survival (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20054.714,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.030) and overall survival (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20055.826,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.009) compared to those with extensive dissections. Subgroup analyses revealed that this association persisted in patients with positive lymph node metastasis but was less evident in those without metastasis, likely due to group imbalance. Propensity score matching analysis further supported the association between fewer lymph node dissections and improved survival outcomes. However, multivariate analysis indicated that the number of lymph nodes dissected was not an independent prognostic factor. This study revealed that a lower number of lymph node dissections is associated with improved recurrence-free survival and overall survival in GC patients receiving ICIs, suggesting a potential benefit of preserving immune-active lymph nodes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048746","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:17Z","timestamp":1779469217000},"page":"e48746","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Impact of lymph node dissection on survival outcomes in gastric cancer patients receiving immune checkpoint inhibitors"],"prefix":"10.1097","volume":"105","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Yin","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7693-9236","authenticated-orcid":false,"given":"Yuehua","family":"Xu","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer.","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"103841","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world.","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives.","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"188615","DOI":"10.1016\/j.bbcan.2021.188615","article-title":"Advances in clinical immunotherapy for gastric cancer.","volume":"1876","author":"Li","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-024-01578-x","article-title":"Recent developments in immunotherapy for gastrointestinal tract cancers.","volume":"17","author":"Chong","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1245\/s10434-019-07700-5","article-title":"Laparoscopic suprapancreatic lymph node dissection using a systematic mesogastric excision concept for gastric cancer.","volume":"27","author":"Kumamoto","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejso.2021.04.019","article-title":"Lymph node dissection for gastric cancer: establishment of D2 and the current position of splenectomy in Europe and Japan.","volume":"47","author":"Faiz","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"E630","DOI":"10.1503\/cjs.019821","article-title":"Lymph node mapping in gastric cancer: a pilot study in Western patients.","volume":"65","author":"Watanabe","year":"2022","journal-title":"Can J Surg"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1097\/JS9.0000000000001626","article-title":"Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: a real-world study.","volume":"110","author":"Liu","year":"2024","journal-title":"Int J Surg"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41467-022-35431-x","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance.","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"1038118","DOI":"10.3389\/fnut.2022.1038118","article-title":"Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.","volume":"9","author":"Sun","year":"2022","journal-title":"Front Nutr"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"152209","DOI":"10.1016\/j.anndiagpath.2023.152209","article-title":"Prognostic role of the number of resected and negative lymph nodes in Spanish patients with gastric cancer.","volume":"67","author":"Del Arco","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1245\/s10434-016-5494-7","article-title":"Influence of total lymph node count on staging and survival after gastrectomy for gastric cancer: an analysis from a two-institution database in China.","volume":"24","author":"Lu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3748\/wjg.v20.i13.3640","article-title":"Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.","volume":"20","author":"Jiao","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10585-021-10091-1","article-title":"Cancer neoantigens as potential targets for immunotherapy.","volume":"39","author":"Ma","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"R20-20260707","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment.","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol Med"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review.","volume":"22","author":"Oura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"eabb6981","DOI":"10.1126\/scitranslmed.abb6981","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment.","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance.","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.immuni.2023.07.008","article-title":"Lymph node sharing between pancreas, gut, and liver leads to immune crosstalk and regulation of pancreatic autoimmunity.","volume":"56","author":"Brown","year":"2023","journal-title":"Immunity"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","article-title":"Same yet different - how lymph node heterogeneity affects immune responses.","volume":"24","author":"de Casas","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/j.jcrs.0000000000000455","article-title":"Effect of anti-inflammatory regimen on early postoperative inflammation after cataract surgery.","volume":"47","author":"Erichsen","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/s41467-022-35096-6","article-title":"Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer.","volume":"13","author":"Sui","year":"2022","journal-title":"Nat Commun"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10585-023-10261-3","article-title":"Interrogating the roles of lymph node metastasis in systemic immune surveillance.","volume":"41","author":"Basto","year":"2024","journal-title":"Clin Exp Metastasis"},{"key":"R29-20260707","doi-asserted-by":"crossref","first-page":"5516399","DOI":"10.1155\/2021\/5516399","article-title":"Immune characters and plasticity of the sentinel lymph node in colorectal cancer patients.","volume":"2021","author":"Li","year":"2021","journal-title":"J Immunol Res"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10120-024-01497-3","article-title":"Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial.","volume":"27","author":"Park","year":"2024","journal-title":"Gastric Cancer"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ejso.2020.02.007","article-title":"The sentinel lymph node biopsy technique in papillary thyroid carcinoma: the issue of false-negative findings.","volume":"46","author":"Garau","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"R32-20260707","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmig.2020.12.025","article-title":"Controversies in sentinel lymph node biopsy for gynecologic malignancies.","volume":"28","author":"Rossi","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"R33-20260707","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/j.semnuclmed.2022.01.006","article-title":"Sentinel lymph node methods in breast cancer.","volume":"52","author":"Giammarile","year":"2022","journal-title":"Semin Nucl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:00:48Z","timestamp":1783414848000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048746","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2025-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}